Soleus Capital Management’s Halozyme HALO Stock Holding History

Soleus Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-44,100	Closed	-$2M	–	78
2021 Q2	$2M	Buy	+44,100	New	+$1.95M	0.31%	51

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Soleus Capital Management's HALO Position: Q3 2021 in Review

Soleus Capital Management sold out of Halozyme (HALO) in Q3 2021, closing a stake of 44,100 shares — an estimated $2M sold.

Soleus Capital Management first reported a position in HALO in Q2 2021 and held it in 1 quarter. The position peaked at $2M in Q2 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q3 2021.

Soleus Capital Management reported no remaining Halozyme position as of Q3 2021 after selling out during the quarter.
Soleus Capital Management sold 44,100 Halozyme shares in Q3 2021, an estimated $2M.
Soleus Capital Management first reported a position in Halozyme in Q2 2021 and held it in 1 quarter.
Soleus Capital Management's Halozyme position peaked at $2M in Q2 2021.
324 funds tracked by Wall St. Rank held Halozyme as of Q3 2021.

Based on Soleus Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.